Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $638.23 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $159.14 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $78.06 | 4 | $0 (2019) |
| ABBVIE INC. | $52.53 | 2 | $0 (2023) |
| Allergan, Inc. | $42.03 | 2 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $41.83 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $31.37 | 2 | $0 (2018) |
| Novo Nordisk Inc | $28.58 | 2 | $0 (2018) |
| Abbott Laboratories | $24.02 | 1 | $0 (2019) |
| Ironwood Pharmaceuticals, Inc | $23.80 | 1 | $0 (2018) |
| Amarin Pharma Inc. | $23.46 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $34.97 | 1 | ABBVIE INC. ($34.97) |
| 2021 | $176.70 | 2 | Stryker Corporation ($159.14) |
| 2020 | $35.19 | 2 | Allergan, Inc. ($20.29) |
| 2019 | $140.00 | 7 | Abbott Laboratories ($24.02) |
| 2018 | $181.44 | 11 | Janssen Pharmaceuticals, Inc ($37.83) |
| 2017 | $69.93 | 4 | SANOFI-AVENTIS U.S. LLC ($20.31) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.97 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2021 | Stryker Corporation | T2 (Device) | Food and Beverage | In-kind items and services | $159.14 | General |
| Category: TRAUMA & EXTREMETIES | ||||||
| 03/02/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: VACCINES | ||||||
| 12/02/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/04/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2019 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: ANTIBIOTICS | ||||||
| 07/15/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: VACCINE | ||||||
| 06/03/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Bone Health | ||||||
| 05/12/2019 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Diabetes Care | ||||||
| 12/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/05/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/15/2018 | Kaleo, Inc. | Evzio (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Opioid Antagonist | ||||||
| 09/16/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: VACCINES | ||||||
| 06/18/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Diabetes | ||||||
| 06/04/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Diabetes | ||||||
| 05/21/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/08/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/16/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), BREO, INCRUSE | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2018 | Ironwood Pharmaceuticals, Inc | LINZESS (Drug), DUZALLO, VIBERZI | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Gastroenterology | ||||||
| 01/15/2018 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/18/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), INVOKAMET, OneTouch | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2017 | HOLOGIC INC | HPV (Device) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Diagnostics | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 162 | 172 | $39,808 | $12,308 |
| 2022 | 7 | 535 | 754 | $105,714 | $61,649 |
| 2021 | 9 | 578 | 788 | $95,796 | $60,246 |
| 2020 | 11 | 558 | 794 | $95,747 | $48,428 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 91 | $26,572 | $7,903 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 47 | $9,682 | $2,884 | 29.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $3,278 | $1,444 | 44.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 23 | 23 | $276.00 | $77.00 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 266 | 393 | $61,248 | $35,100 | 57.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 239 | $26,913 | $16,246 | 60.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 16 | 16 | $5,600 | $3,732 | 66.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 35 | 40 | $4,425 | $3,422 | 77.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $5,296 | $2,475 | 46.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 33 | 35 | $1,862 | $345.69 | 18.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $370.00 | $327.98 | 88.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 253 | 365 | $52,925 | $34,083 | 64.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 152 | 239 | $25,095 | $15,508 | 61.8% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 15 | 17 | $5,950 | $4,079 | 68.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $6,448 | $3,602 | 55.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 18 | 22 | $2,150 | $1,957 | 91.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 32 | 33 | $891.00 | $584.89 | 65.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 35 | 39 | $2,145 | $375.90 | 17.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 16 | 16 | $192.00 | $55.68 | 29.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 26 | 26 | $0.26 | $0.26 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 219 | 328 | $47,560 | $24,227 | 50.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 160 | 263 | $27,615 | $12,755 | 46.2% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 15 | 20 | $7,000 | $3,986 | 56.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 26 | 36 | $4,200 | $2,625 | 62.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 24 | 24 | $4,992 | $2,340 | 46.9% |
About Dr. Timothy O'mara, M.D
Dr. Timothy O'mara, M.D is a Internal Medicine healthcare provider based in Wakefield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205879608.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy O'mara, M.D has received a total of $638.23 in payments from pharmaceutical and medical device companies, with $34.97 received in 2023. These payments were reported across 27 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($638.23).
As a Medicare-enrolled provider, O'mara has provided services to 1,833 Medicare beneficiaries, totaling 2,508 services with total Medicare billing of $182,631. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Wakefield, RI
- Active Since 06/14/2006
- Last Updated 07/10/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1205879608
Products in Payments
- T2 (Device) $159.14
- XARELTO (Drug) $59.31
- UBRELVY (Drug) $55.26
- Victoza (Drug) $28.58
- FreeStyle Libre (Device) $24.02
- LINZESS (Drug) $23.80
- Vascepa (Drug) $23.46
- EVENITY (Biological) $22.60
- VRAYLAR (Drug) $21.74
- PRALUENT (Drug) $21.52
- SOLIQUA (Drug) $20.31
- INVOKANA (Drug) $18.75
- QULIPTA (Drug) $17.56
- TRULICITY (Drug) $17.01
- SHINGRIX (Biological) $16.14
- Baxdela (Drug) $15.25
- TRELEGY ELLIPTA (Drug) $15.23
- FARXIGA (Drug) $14.94
- PREVNAR 13 (Biological) $14.90
- HPV (Device) $13.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wakefield
Dr. Bruce Watrous, M.d, M.D
Internal Medicine — Payments: $9,530
Dr. James Rocco, M.d, M.D
Internal Medicine — Payments: $6,711
Monique Pouliot, D.o, D.O
Internal Medicine — Payments: $3,120
Dr. Nitin Damle, Md, MD
Internal Medicine — Payments: $3,102
Heidi Dorris, M.d, M.D
Internal Medicine — Payments: $3,009
Paul Barratt, M.d, M.D
Internal Medicine — Payments: $2,857